One mitochondrial disease patient, who had compound heterozygous NSUN3 mutations, developed symptoms of the disease at the age of 3 months, including muscle weakness, ophthalmoplegia, convergence nystagmus, increased plasma lactate level, microcephaly, and developmental delay13. The gene discussed is NSUN3; the disease is inborn mitochondrial metabolism disorder.